21 CFR 1316.60 - Objections; offer of proof

Cite as21 CFR 1316.60
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
5 practice notes
  • Superior Pharmacy I and Superior Pharmacy II Decision and Order
    • United States
    • Federal Register May 18, 2016
    • May 18, 2016
    ...were offered as a proffer, they should not be included in the record because Respondent had not made an offer of proof as required by 21 CFR 1316.60. Id. The Government further noted that none of the documents were ``self-authenticating'' and many of them, which included patient medical rec......
  • Trinity Pharmacy II; Decision and Order
    • United States
    • Federal Register February 20, 2018
    • February 20, 2018
    ...556(d) (``A party is entitled . . . to conduct such cross-examination as may be required for a full and true disclosure of the facts.''); 21 CFR 1316.60. \44\ For the same reason, I reject Trinity II's Exception that the CALJ's in Limine Order ``did not permit the Respondents to present rel......
  • Farmacia Yani; Decision and Order
    • United States
    • Federal Register May 20, 2015
    • May 20, 2015
    ...See ALJ Ex. 7. Finally, the document was not included with the transmitted record as a rejected exhibit as it should have been. See 21 CFR 1316.60. Ms. Santiago-Soto also testified in Respondent's case-in-chief. Ms. Santiago-Soto testified that prior to her arrest on November 30, 2011, she ......
  • Admin. Subpoena Walgreen Co. v. U.S. Drug Enforcement Admin., No. 1:12–mc–43 (JCC/IDD).
    • United States
    • United States District Courts. 4th Circuit. United States District Court (Eastern District of Virginia)
    • December 21, 2012
    ...as to the issue. DEA regulations provide an opportunity for Walgreens to “object[ ] to the admission or rejection of any evidence.” 21 C.F.R. § 1316.60. Indeed, an ALJ can rule on a claim of privilege “just as he could rule on any issue of evidence presented to him during the course of a he......
  • Request a trial to view additional results
2 cases
  • Admin. Subpoena Walgreen Co. v. U.S. Drug Enforcement Admin., No. 1:12–mc–43 (JCC/IDD).
    • United States
    • United States District Courts. 4th Circuit. United States District Court (Eastern District of Virginia)
    • December 21, 2012
    ...as to the issue. DEA regulations provide an opportunity for Walgreens to “object[ ] to the admission or rejection of any evidence.” 21 C.F.R. § 1316.60. Indeed, an ALJ can rule on a claim of privilege “just as he could rule on any issue of evidence presented to him during the course of a he......
  • Walgreen Co. v. U.S. Drug Enforcement Admin., 1:12-mc-43 (JCC/IDD)
    • United States
    • United States District Courts. 4th Circuit. United States District Court (Eastern District of Virginia)
    • December 21, 2012
    ...as to the issue. DEA regulations provide an opportunity for Walgreens to "object[] to the admission or rejection of any evidence." 21 C.F.R. § 1316.60. Indeed, an ALJ can rule on a claim of privilege "just as he could rule on any issue of evidence presented to him during the course of a hea......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT